# Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine

> **NCT00389532** · PHASE4 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 116 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza Virus Vaccine (2006-2007 Fluzone® vaccine)
- **BIOLOGICAL:** Influenza Virus Vaccine (2006-2007 Fluzone® vaccine)

## Key facts

- **NCT ID:** NCT00389532
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-04
- **Final completion:** 2008-09
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389532, "Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00389532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*